Ablynx wins second European Mediscience Award
Ablynx has won the award for 'Best Technology' at the 2010 European Mediscience Awards for the second time in two years.
The European Mediscience Awards Dinner, sponsored by Piper Jaffray, is the largest annual gathering of quoted biotech and life sciences companies in Europe. It celebrates the best in the sector and highlights the achievements of individuals and companies. The event recognises the importance of access to the capital markets to fund growth and innovation and is attended by specialist investors, advisors, media and analysts.
Ablynx is focused on the discovery and development of Nanobodies, a novel class of antibody-derived therapeutic proteins based on single-domain antibody fragments, for a range of serious life-threatening human diseases.
